Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medifast (MED) Gross Profit (2016 - 2025)

Historic Gross Profit for Medifast (MED) over the last 16 years, with Q4 2025 value amounting to $52.1 million.

  • Medifast's Gross Profit fell 4089.71% to $52.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $275.2 million, marking a year-over-year decrease of 3810.76%. This contributed to the annual value of $275.2 million for FY2025, which is 3810.78% down from last year.
  • Latest data reveals that Medifast reported Gross Profit of $52.1 million as of Q4 2025, which was down 4089.71% from $62.2 million recorded in Q3 2025.
  • Over the past 5 years, Medifast's Gross Profit peaked at $321.7 million during Q2 2022, and registered a low of $52.1 million during Q4 2025.
  • In the last 5 years, Medifast's Gross Profit had a median value of $194.0 million in 2023 and averaged $188.2 million.
  • Per our database at Business Quant, Medifast's Gross Profit surged by 8437.35% in 2021 and then crashed by 4833.72% in 2024.
  • Medifast's Gross Profit (Quarter) stood at $278.3 million in 2021, then decreased by 16.06% to $233.6 million in 2022, then tumbled by 39.48% to $141.4 million in 2023, then tumbled by 37.6% to $88.2 million in 2024, then crashed by 40.9% to $52.1 million in 2025.
  • Its last three reported values are $52.1 million in Q4 2025, $62.2 million for Q3 2025, and $76.6 million during Q2 2025.